Ecovia Bio

Ecovia Bio is an advanced biotechnology company that specializes in the development and commercialization of sustainable, high-performance biopolymers derived from a proprietary, feedstock-flexible fermentation process. Spun out of the University of Michigan, the company focuses on producing gamma polyglutamic acid (γ-PGA) and its derivatives, marketed under brands such as AzuraBase and AzuraGel. By optimizing microbial strains, Ecovia Bio offers a cost-effective, 100% biobased, and readily biodegradable alternative to traditional synthetic polyacrylates, effectively addressing environmental concerns related to microplastic pollution and high greenhouse gas emissions. The company operates a commercial-scale production facility in Livonia, Michigan, which it commissioned to provide domestically manufactured solutions across diverse industrial applications.

Ecovia Bio’s technology provides essential functional benefits to partners in the personal care, cosmetics, agriculture, and hygiene sectors, serving as high-performance humectants, rheology modifiers, and superabsorbents. These bio-based materials are designed to perform as well or better than their synthetic counterparts while supporting corporate sustainability goals and supply chain resilience. The company has secured third-party validation for its technology, including USDA 100% Biobased certification and OECD 301B ready biodegradability status. Supported by Series B funding, Ecovia Bio is actively scaling its manufacturing capacity to meet growing global demand for environmentally responsible polymer alternatives.